Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increlex® (Mecasermin [rDNA Origin] Injection) Growth Forum Database - IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

NCT00747604 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00747604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00747604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increlex® (Mecasermin [rDNA Origin] Injection) Growth Forum Database - IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex
Lead sponsor
Ipsen
Phase
Observational
Overall status
Terminated
Start date
June 30, 2006
Completion date
May 31, 2014
Enrollment
1,378 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary insulin-like growth factor-1 deficiency